Filters
on 24 Sep 2010
OTSUKA PHARMACEUTICAL CO. LTD.
1349281 · 29 May 2007
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the treatment of the central nervous system, namely stimulants, antipyretic analgesics, anti-epileptics, analeptics, hypnotic sedatives, general anesthetics and anti-motionsickness agents; pharmaceutical preparations for the treatment of the peripheral nervous system, namely local anesthetics, skeletal muscle relaxants, anhidrotics, autonomics, antispasmodics and diaphoretics; pharmaceutical preparations for the treatment of sensory organs, namely antiglaucoma and anti-intraocular hypertension drugs; pharmaceutical preparations for the treatment of respiratory organs, namely respiratory stimulants, anti-cough drops and anti-tussive expectorants; pharmaceutical preparations for the treatment of digestive organs, namely gastrointestinal cleaning agents, clysters, evacuants [purgatives], stomachics and digestives, mouth cavity cleansers for medical purposes, breath refreshers, emetics, antacids, intestinal regulators, antiemetics, castor oil for medical purposes, tooth prophylactics, cholagogues; pharmaceutical preparations for the treatment of cardiovascular system, namely cardiotonics, antihypertensives, vasoconstrictors, capillary stabilizers, cerebral haemorrhage prophylactics agents, antiarrhythmic agents and diuretics; pharmaceutical preparations for the treatment of dermatological disorders, and for the treatment of cancer (chemotherapeutic agents); pharmaceutical preparations for the activation of cellular function, for suppression of tumors; allergy medications; hormones for human use; vitamins; antibiotics; pharmaceutical preparations, namely, parenteral solutions used to supply amino acids in the following cases: hypoproteinemia, malnutrition and pre- and/or post-operative states; oral nutritional supplements and/or tube feeding formula for the nutritional support of diabetic patients; pharmaceutical preparations containing a-interferon for the treatment of viremia caused by viral hepatitis type B and C and treatment of hypernephroma; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of Hepatitis C; pharmaceutical drugs and medicines, namely, contrast medium for digestive organs; medical diagnostic reagent for measuring gas content in exhaled breath to determine existence of micro-organism in human digestive organs and medical reagents for diseases in digestive organs; diagnostic medical, chemical and pharmaceutical preparations for detecting Helicobacter-pylori for use in breath tests; pharmaceutical preparations for the eradication of helicobacter-pylori; blood and body fluid agents.
Pharmaceutical preparations for the treatment of the central nervous s...
Image Search
Drag and drop or upload to search any image